Gastric disorders: modifications of gastric content, antacids and drugs influencing gastric secretions and motility

• Published in: Anaesthesia and intensive care medicine 2015-01, Vol.16 (1), p.26-29
• Main Authors: O’Neil, Daniel H.R, Leonard, Anton
• Format: Article
• Language: English
• Subjects: Anesthesia & Perioperative Care; Antihistamines; prokinetics; proton pump inhibitors
• ISSN: 1472-0299; 1878-7584
• DOI: 10.1016/j.mpaic.2014.10.008

Abstract Gastric disorders have clinical implications in both anaesthesia and critical care medicine. Aspiration of acidic gastric contents in the perioperative setting is linked to pneumonitis and later development of pneumonia. Pharmacological strategies to minimize this risk include histamine-2 receptor antagonists, sucralfate, proton pump inhibitors and sodium citrate. Use of gastric acid-suppressing therapy is widespread in critical care. The aim is to reduce the incidence of stress-related mucosal bleeding. Intestinal failure is common in critical illness. Medications that decrease gastric motility and contribute to ileus, include opioid analgesics, catecholamines and α2 -adrenoceptor antagonists. Current pharmacological strategies for increasing gastric motility include the use of metoclopramide and erythromycin either alone or in combination. Limited efficacy has been demonstrated with these medications. A range of further medications, with different drug targets, are being investigated as alternatives. These include motilin agonists, peripherally acting opioid receptor antagonists, cholecystokinin antagonists, 5-HT4 antagonists and cholinesterase inhibitors.